☆ 4.1 Article

Financial Conflicts of Interest Among the Authors of the Clinical Practice Guidelines for Rheumatoid Arthritis in Japan

CUREUS JOURNAL OF MEDICAL SCIENCE (2023)

Related references

Note: Only part of the references are listed.

Article Rheumatology

Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019

Anju Murayama et al.

Summary: The study found that there is a prevalent and substantial financial relationship between rheumatologists and pharmaceutical companies in Japan. From 2016 to 2019, 92 major pharmaceutical companies paid a total of $55,246,485 in personal payments for lecturing, writing, and consulting to 5038 board-certified rheumatologists. These payments were primarily concentrated on doctors in authoritative and influential positions.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines

Anju Murayama et al.

Summary: This study found extensive financial conflicts of interest between pharmaceutical companies and guideline authors in Japan, with over 40% of recommendations based on low-quality evidence. The Japanese Society of Gastroenterology guideline development process lacks transparency and sufficient conflict of interest policies compared to global standards.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Add to Collection

Letter Rheumatology

Trend in Industry Payments to Rheumatologists in the United States During the COVID-19 Pandemic Between 2013 and 2021

Anju Murayama et al.

JOURNAL OF RHEUMATOLOGY (2023)

Add to Collection

Article Health Care Sciences & Services

Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020

Anju Murayama et al.

Summary: This study evaluated the magnitude and prevalence of personal payments to executive board members of 15 medical associations in Japan. The findings revealed that nearly all board members had substantial financial relationships with pharmaceutical companies over the past 5 years.

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2023)

Add to Collection

Article Rheumatology

Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors' Self-Citation Rate in Japan and the United States

Hanano Mamada et al.

Summary: This study aimed to assess financial conflicts of interest (COI) and nonfinancial COI among psoriatic arthritis (PsA) clinical practice guideline (CPG) authors in Japan and the US, and to evaluate the quality of evidence and strength of recommendations of PsA CPGs. The study found that approximately 91.3% of Japanese authors and 84.0% of US authors received at least one payment between 2016 and 2018. The average payment amount per author was $145,018 in Japan and $162,825 in the US. Furthermore, undisclosed financial COI were found in 78.3% of authors of the JDA PsA CPG and 48.0% of authors of the ACR PsA CPG.

ARTHRITIS CARE & RESEARCH (2023)

Add to Collection

Article Multidisciplinary Sciences

Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019

Anju Murayama et al.

Summary: There is a prevalent financial relationship between dermatologists and pharmaceutical companies in Japan. This study examined the personal payments made to board-certified dermatologists by the Japanese Dermatological Association from pharmaceutical companies between 2016 and 2019. The findings showed that a large number of dermatologists received personal payments, with an increasing trend over the four years, and higher payments were associated with certain dermatologist demographics.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Medicine, General & Internal

Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019

Anju Murayama et al.

Summary: This study explores the financial relationships between pharmaceutical companies and gastroenterologists in Japan. The findings indicate that over half of board-certified gastroenterologists received personal payments totaling $89,151,253 from 84 pharmaceutical companies between 2016 and 2019. However, the study also reveals that only a few influential gastroenterologists accepted substantial amounts of payment.

BMJ OPEN (2023)

Add to Collection

Article Urology & Nephrology

Research and Nonresearch Industry Payments to Nephrologists in the United States between 2014 and 2021

Anju Murayama et al.

Summary: This study found that 87% of nephrologists in the US received nonresearch payments, while only 12% received research payments. Male nephrologists were more likely to receive research payments and nonresearch payments increased by 8% among male nephrologists. A small percentage of nephrologists received the majority of nonresearch payments.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Add to Collection

Article Respiratory System

A 9-Year Investigation of Healthcare Industry Payments to Pulmonologists in the United States

Anju Murayama et al.

Summary: Nearly 90% of pulmonologists in the United States receive nonresearch and research payments from the healthcare industry, with nonresearch payments increasing continuously.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2023)

Add to Collection

Letter Infectious Diseases

Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan

Takanao Hashimoto et al.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Add to Collection

Letter Gastroenterology & Hepatology

Letter to the editor: Are clinical practice guidelines for hepatitis C by the American Association for the Study of Liver Diseases and Infectious Diseases Society of America evidence based? Financial conflicts of interest and assessment of quality of evidence and strength of recommendations

Anju Murayama et al.

HEPATOLOGY (2022)

Add to Collection

Article Urology & Nephrology

Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline

Anju Murayama et al.

Summary: This study examined the financial and nonfinancial conflicts of interest among authors of CKD guidelines in Japan and found that most of the recommendations were based on low-quality evidence tied to pharmaceutical companies. The study also revealed the lack of rigorous and transparent conflict of interest policies for nephrology guideline authors.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Add to Collection

Article Otorhinolaryngology

Financial and Intellectual Conflicts of Interest Among Japanese Clinical Practice Guidelines Authors for Allergic Rhinitis

Anju Murayama et al.

Summary: The study revealed significant financial relationships between allergic rhinitis CPG authors and pharmaceutical companies in Japan, particularly those marketing novel drugs. Additionally, authors had relatively high self-citation rates, indicating the need for more rigorous COI management strategies.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)

Add to Collection

Article Environmental Sciences

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019

Anju Murayama et al.

Summary: This study retrospectively assessed the financial relationships between board-certified infectious disease specialists in Japan and pharmaceutical companies. The results showed substantial financial ties between these specialists and the companies, with higher-ranked specialists having stronger financial connections.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Add to Collection

Letter Gastroenterology & Hepatology

Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society

Anju Murayama et al.

DISEASES OF THE ESOPHAGUS (2022)

Add to Collection

Article Respiratory System

Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019

Anju Murayama et al.

Summary: This study examined the financial relationships between respiratory specialists in Japan and pharmaceutical companies from 2016 to 2019. The findings revealed that a majority of respiratory specialists received increasing personal payments from pharmaceutical companies for lecturing, consulting, and writing. These financial relationships with pharmaceutical companies could potentially lead to conflicts of interest among respiratory physicians.

RESPIRATION (2022)

Add to Collection

Article Medicine, General & Internal

Managing conflicts of interest in the development of health guidelines

Gregory Traversy et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

Add to Collection

Article Health Care Sciences & Services

Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017

Kayo Harada et al.

Summary: The study revealed financial conflicts of interest between Japanese hematologists and pharmaceutical companies, which could adversely affect the promotion and use of drugs in clinical practice guidelines. There was an association between pharmaceutical payments and drug approvals, emphasizing the need for greater transparency to clarify these relationships.

HEALTH POLICY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatment

Futa Kida et al.

Summary: This study examined the payments made by pharmaceutical companies to the authors of the Hepatitis C Clinical Practice Guidelines and the financial conflicts of interest reported by the authors. The results showed that all authors received payments from pharmaceutical companies, with a strong relationship to the companies manufacturing DAAs.

LIVER INTERNATIONAL (2021)

Add to Collection

Article Multidisciplinary Sciences

Analysis of conflict of interest policies among organizations producing clinical practice guidelines

J. Henry Brems et al.

Summary: The study evaluated adherence to conflict of interest policies among multiple organizations and found that most organizations' policies did not meet the standards set by the Institute of Medicine, and that these organizations often violated their own policies. This could impact public trust in clinical practice guidelines.

PLOS ONE (2021)

Add to Collection

Article Rheumatology

Industry Payments to Practicing US Rheumatologists, 2014-2019

Michael S. Putman et al.

Summary: This study investigated the nature, quantity, and geographic distribution of payments from the pharmaceutical industry to US rheumatologists. Results showed that the majority of rheumatologists received less than $5,000, while a small number received over $100,000 each, accounting for a large portion of the total payments. The value of industry payments increased over time, and male rheumatologists received significantly higher payments than female rheumatologists.

ARTHRITIS & RHEUMATOLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan

Kana Yamamoto et al.

Summary: Most Japanese authors of urology clinical practice guidelines received substantial payments from pharmaceutical companies, but inadequate transparency in disclosing financial conflicts may compromise the integrity of UCPG.

INTERNATIONAL UROGYNECOLOGY JOURNAL (2021)

Add to Collection

Article Multidisciplinary Sciences

Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan

Anju Murayama et al.

PLOS ONE (2020)

Add to Collection

Article Medicine, General & Internal

Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018

Alexander C. Fanaroff et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Add to Collection

Letter Medicine, General & Internal

The Evidence Basis for the American College of Rheumatology Practice Guidelines

Ali Duarte-Garcia et al.

JAMA INTERNAL MEDICINE (2018)

Add to Collection

Article Medicine, General & Internal

Types and Distribution of Payments From Industry to Physicians in 2015

Kathryn R. Tringale et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Add to Collection

Article Rheumatology

TIMELINE Managing rheumatic and musculoskeletal diseases - past, present and future

Gerd R. Burmester et al.

NATURE REVIEWS RHEUMATOLOGY (2017)

Add to Collection

Review Rheumatology

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

Josef S. Smolen et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

Add to Collection

Article Health Care Sciences & Services

Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase

Adrienne Shnier et al.

BMC HEALTH SERVICES RESEARCH (2016)

Add to Collection

Article Oncology

Distribution and Patterns of Industry-Related Payments to Oncologists in 2014

Deborah C. Marshall et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Add to Collection

Article Medicine, General & Internal

Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study

Paul Campsall et al.

PLOS MEDICINE (2016)

Add to Collection

Article Oncology

Distribution and Patterns of Industry-Related Payments to Oncologists in 2014

Deborah C. Marshall et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Add to Collection

Article Medicine, General & Internal

Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines

Holger J. Schunemann et al.

ANNALS OF INTERNAL MEDICINE (2015)

Add to Collection

Article Ethics

Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study

Julie Bolette Brix Bindslev et al.

BMC MEDICAL ETHICS (2013)

Add to Collection

Article Health Care Sciences & Services

Conflicts of interest and the quality of recommendations in clinical guidelines

Lisa Cosgrove et al.

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2013)

Add to Collection

Editorial Material Medicine, General & Internal

Ensuring the integrity of clinical practice guidelines: a tool for protecting patients

Jeanne Lenzer et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

Add to Collection

Article Ethics

Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process

L. Johnson et al.

JOURNAL OF MEDICAL ETHICS (2009)

Add to Collection

Editorial Material Medicine, General & Internal

GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations

Gordon H. Guyatt et al.

BRITISH MEDICAL JOURNAL (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.